# Globus Medical, Inc. (GMED): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for Globus Medical, Inc. (GMED) is 89/100, ranked against 24,000+ stocks in 35 markets (Quality 83, Value 60, Momentum 46, each scored against its sector).

- StockRank: 89/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 83, Value 60, Momentum 46: each a 0-100 percentile within Healthcare.
- Position: #3,000 overall, #341 in Healthcare.
- Listing: United States, NYQ; Healthcare / Medical Devices.
- Last close: 81.41 USD on 23 Oct 2026.
- Insider filings, last 180 days: directors sold USD 6.4M.
- Buybacks, last 180 days: the company bought back USD 136.1M on 1 day.

Source: https://moatmap.ai/stock/GMED
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker